Nastech Pharmaceutical Co., P&G deal

PG ended a 2006 deal that granted it worldwide rights to NSTK's intranasal teriparatide to treat osteoporosis (see BioCentury, Feb. 6, 2006). A PG spokesperson said that after reviewing the most recen...